We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$5.62B
AUM Growth
-$440M
Cap. Flow
-$1B
Cap. Flow %
-17.83%
Top 10 Hldgs %
68.4%
Holding
193
New
70
Increased
43
Reduced
30
Closed
34

Sector Composition

Rank Sector Weight
1 Financials 8.62%
2 Utilities 5.17%
3 Consumer Discretionary 4.41%
4 Healthcare 3.27%
5 Real Estate 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KTOS icon
126
Kratos Defense & Security Solutions
KTOS
$11.4B
$422K 0.01%
+27,000
New +$432K
RPTX
127
DELISTED
Repare Therapeutics
RPTX
$419K 0.01%
+13,500
New +$433K
ES icon
128
Eversource Energy
ES
$27.2B
$416K 0.01%
+5,000
New +$414K
SIBN icon
129
SI-BONE Inc
SIBN
$834M
$402K 0.01%
25,189
-600
-2% -$9.46K
BUD icon
130
AB InBev
BUD
$165B
$394K 0.01%
8,000
ESNT icon
131
Essent Group
ESNT
$6.33B
$374K 0.01%
+10,300
New +$316K
BIOR
132
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$360K 0.01%
+160
New +$436K
NNN icon
133
CALL
NNN REIT
NNN
$8.99B
$355K 0.01%
+10,000
New +$327K
SRC
134
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$349K 0.01%
+10,000
New +$303K
UAL icon
135
United Airlines
UAL
$42.1B
$346K 0.01%
+10,000
New +$300K
TW icon
136
Tradeweb Markets
TW
$21.6B
$291K 0.01%
5,000
-2,259
-31% -$130K
CSTL icon
137
Castle Biosciences
CSTL
$979M
$283K 0.01%
+7,500
New +$256K
EVFM
138
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$283K 0.01%
+6,667
New +$449K
SLQT icon
139
SelectQuote
SLQT
$121M
$279K 0.01%
+11,001
New +$295K
LYRA
140
DELISTED
LYRA THERAPEUTICS INC
LYRA
$270K ﹤0.01%
+476
New +$348K
ORIC icon
141
Oric Pharmaceuticals
ORIC
$1.4B
$270K ﹤0.01%
+8,000
New +$255K
PING
142
DELISTED
Ping Identity Holding Corp.
PING
$257K ﹤0.01%
+8,000
New +$212K
RNAM
143
DELISTED
Avidity Biosciences
RNAM
$254K ﹤0.01%
+9,000
New +$259K
GBIO
144
DELISTED
Generation Bio
GBIO
$252K ﹤0.01%
+1,200
New +$267K
PCVX icon
145
Vaxcyte
PCVX
$8.64B
$221K ﹤0.01%
+7,000
New +$225K
CHX
146
DELISTED
ChampionX
CHX
$216K ﹤0.01%
+22,103
New +$203K
GTM
147
ZoomInfo Technologies
GTM
$1.22B
$204K ﹤0.01%
+4,000
New +$191K
BCYC
148
Bicycle Therapeutics
BCYC
$292M
$197K ﹤0.01%
12,500
TBIO
149
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$179K ﹤0.01%
+10,000
New +$151K
LUV icon
150
Southwest Airlines
LUV
$23B
$171K ﹤0.01%
+5,000
New +$159K

Similar funds

Pentwater Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Pentwater Capital Management held 193 positions worth $5.62B, down 7.3% from $6.06B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Pentwater Capital Management withdrew a net $1B in Q2 2020, closing 34 positions and reducing 30 holdings. Its most notable exit was Mellanox Technologies, Ltd., an estimated $375M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, up from 6.8% a quarter earlier, followed by Utilities and Consumer Discretionary.

Against the trend, Pentwater Capital Management opened a new position in 58.com Inc worth $267M.

  • Pentwater Capital Management's largest Q2 2020 buy was 58.com Inc: 4,942,800 shares worth $267M.
  • Pentwater Capital Management added most to Tiffany & Co. in Q2 2020, an estimated $154M increase.
  • Pentwater Capital Management's biggest Q2 2020 reduction was Boeing, cutting an estimated $78.7M.
  • Pentwater Capital Management fully exited Mellanox Technologies, Ltd. in Q2 2020, selling an estimated $375M.
  • Pentwater Capital Management's ten largest holdings make up 68% of its $5.62B portfolio in Q2 2020.
  • Pentwater Capital Management opened 70 new positions and closed 34 in Q2 2020.
  • Pentwater Capital Management's portfolio value fell 7.3% quarter-over-quarter to $5.62B.

Based on Pentwater Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.